Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This standardized perioperative medication regimen is utilized by Hospital da Luz, Portugal, as a baseline treatment for patients undergoing orthopedic surgery with neuraxial anesthesia. The combination therapy consists of four distinct pharmaceutical agents: cefazolin, a first-generation cephalosporin antibiotic used for surgical site infection prophylaxis; ketorolac, a potent non-steroidal anti-inflammatory drug (NSAID) for acute pain management; pantoprazole, a proton pump inhibitor (PPI) administered to prevent stress-induced gastric ulcers and reduce acid secretion; and paracetamol, a non-opioid analgesic and antipyretic. In the context of clinical research (NCT04441411), this regimen is administered to all study participants to ensure a consistent baseline of care while evaluating the comparative effects of midazolam versus propofol sedation on core temperature variations.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on cefazolin + ketorolac + pantoprazole + paracetamol.